Cellectis (CLLS) Operating Expenses (2023)
Cellectis has reported Operating Expenses over the past 1 years, most recently at -$64.0 million for Q4 2023.
- Quarterly results put Operating Expenses at -$64.0 million for Q4 2023, changed N/A from a year ago — trailing twelve months through Dec 2025 was -$41.7 million (down 160.29% YoY), and the annual figure for FY2023 was $10.9 million, down 90.52%.
- Operating Expenses for Q4 2023 was -$64.0 million at Cellectis, down from $22.3 million in the prior quarter.
- Over the last five years, Operating Expenses for CLLS hit a ceiling of $25.7 million in Q2 2023 and a floor of -$64.0 million in Q4 2023.